NCT00745862 Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma Status COMPLETED Phase N/A
NCT00745381 A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors Status COMPLETED Phase N/A
NCT00745160 Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes Status COMPLETED Phase N/A
NCT00741039 Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older Status COMPLETED Phase PHASE2
NCT00740636 Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00739141 Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. Status COMPLETED Phase PHASE2
NCT00737438 Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00736619 Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) Status COMPLETED Phase PHASE1
NCT00735150 Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk Status COMPLETED Phase N/A
NCT00729638 RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00722605 Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00721630 Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00716456 Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib Status COMPLETED Phase PHASE1/PHASE2
NCT00715611 Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00714948 Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT00713219 Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2